Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial

Authors: Achim J. Kaasch, Luis Eduardo López-Cortés, Jesús Rodríguez‐Baño, José Miguel Cisneros, M.D. Navarro, Gerd Fätkenheuer, Norma Jung, Siegbert Rieg, R. Lepeule, Laetitia Coutte, Louis Bernard, Adrien Lemaignen, Katrin Kösters, Colin R. MacKenzie, Àlex Soriano, Stefan Hagel, B. Fantin, Matthieu Lafaurie, Jean‐Philippe Talarmin, Aurélien Dinh, Thomas Guimard, David Boutoille, Tobias Welte, Stefan Reuter, Jan Kluytmans, Marisa Martín, E. Forestier, Hartmut Stocker, Virginie Vitrat, Pierre Tattevin, Anna Rommerskirchen, Marion Noret, Anne Adams, Winfried V. Kern, Martin Hellmich, Harald Seifert, Adoración Valiente, Marina de Cueto, Ángel Rodríguez, José Molina, Julia Fischer, Gregor Paul, Sébastien Gallien, Vincent Fihman, Marion Lacasse, François Coustillères, Christian Becker, André Fuchs, Laura Morata, Sebastian Weis, Diane Ponscarme, L. Khatchatourian, É. Rouveix, Dominique Merrien, R. Lecomte, Jacobien Veenemans, Helem Vílchez, Johanna Kessel, Marc J. M. Bonten, Jan Rupp, Laurent Hocqueloux, F. Lucht, J.‐P. Stahl, A. L. M. Vlek, Reinhild Prinz‐Langenohl, Violaine TOLSMA - The Lancet 2024 cited by 81